Fig. 2From: Infiltrating stromal immune cells in inflammatory breast cancer are associated with an improved outcome and increased PD-L1 expressionPatients that had a complete pathological response (pCR) showed more PD-L1 immunoreactivity (73.3% PD-L1+ sTIL) than patients without a complete response (36.9% PD-L1+ sTIL). χ2 = 15.3, P = 0.002Back to article page